FindTrial
Sign In

Clinical Evaluation of Two Doses of Clonidine As An Adjuvant To Bupivacaine In Supraclavicular Brachial Plexus Block

Clinical Evaluation of Two Different Doses of Clonidine As An Adjuvant To Bupivacaine In Ultrasound Guided Supraclavicular Brachial Plexus Block For Paediatric Upper Limb Surgeries

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/08/020961
Enrollment
42
Registered
2019-08-29
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M253- Other instability of joint

Interventions

Intervention1: clonidine 0.5 micrograms/kg to be given alongwith 0.5 ml/kg bupivacaine: clonidine is added to increase the duration of the block

Sponsors

Rohan Sharma
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA Grade 1 and 2

Exclusion criteria

Exclusion criteria: Previous nerve injuries, History of drug allergy, History of bleeding disorders, Patients on anticoagulants, Patients on sedative drugs, Any major systemic illness

Design outcomes

Primary

MeasureTime frame
Time to first rescue analgesic in the postoperative periodTimepoint: Time to first rescue analgesic in the postoperative period—

Secondary

MeasureTime frame
sensory and motor block characteristicsTimepoint: complications upto 24 hrs—

Countries

India

Contacts

Public ContactRohan Sharma

Chacha Nehru Bal Chikitsalya

kmlgeeta@rediffmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026